{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:39:58Z","timestamp":1792417198404,"version":"4.4.0"},"reference-count":80,"publisher":"American Chemical Society (ACS)","issue":"41","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024109","name":"Uniwersytet Gdanski","doi-asserted-by":"publisher","award":["539-T120-B197-25"],"award-info":[{"award-number":["539-T120-B197-25"]}],"id":[{"id":"10.13039\/501100024109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024109","name":"Uniwersytet Gdanski","doi-asserted-by":"publisher","award":["539-T120-B261-26"],"award-info":[{"award-number":["539-T120-B261-26"]}],"id":[{"id":"10.13039\/501100024109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A phenanthroline-bearing sulfonamide ligand (L) and its half-sandwich rhodium(III) and iridium(III) complexes, [(\u03b75-Cp*)RhCl(L)]PF6 (1) and [(\u03b75-Cp*)IrCl(L)]PF6 (2), were synthesized to determine how metal coordination and metal identity influence structure, solution properties, and anticancer responses. Single-crystal X-ray diffraction established closely related piano-stool geometries with bidentate N,N-coordination of L, while spectroscopic analyses confirmed the complexes in solution. All compounds were spectroscopically stable for 72 h under the tested conditions. Coordination shifted the lipophilicity of L (log P = 0.78) to hydrophilic values for 1 and 2 (\u22120.65 and \u22120.91, respectively). The complexes weakly inhibited carbonic anhydrase II and displayed low-affinity binding to human serum albumin; the CT-DNA UV\u2013vis experiment was inconclusive because of substantial spectral overlap and was not used to assign a DNA-binding mode. L showed submicromolar-to-low-micromolar cytotoxicity across four cancer cell lines and pronounced time-dependent mitochondrial depolarization in NALM-6 cells. Complex 2 retained micromolar potency but showed weak overall cancer\/nonmalignant discrimination, whereas 1 showed a marked preference for NALM-6 cells (IC50 = 4.41 \u03bcM; HEK-293 IC50 &amp;gt; 100 \u03bcM). In NALM-6 cells, 1 produced a pronounced ROS increase at 6 h that preceded prominent \u03b3H2AX signaling, caspase-3\/7 activation, and apoptosis at 24\u201348 h, while mitochondrial depolarization remained comparatively limited. This temporal ordering is consistent with a redox-associated cellular response but does not by itself establish ROS causality or exclude mitochondrial involvement. These matched analogs demonstrate that Rh(III) versus Ir(III) coordination can reprogram physicochemical and cellular response profiles within the same ligand scaffold and identify 1 as a candidate for further mechanism-guided optimization.<\/jats:p>","DOI":"10.1021\/acs.inorgchem.6c04078","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:01:26Z","timestamp":1790928086000},"page":"24456-24475","source":"Crossref","is-referenced-by-count":0,"title":["Metal-dependent\nStructure, Solution Properties, and\nRedox-Mediated Anticancer Activity of Rhodium(III) and Iridium(III)\nHalf-Sandwich Phenanthroline\u2013Sulfonamide Complexes"],"prefix":"10.1021","volume":"65","author":[{"given":"Natalia","family":"Z\u0307ukowska","sequence":"first","affiliation":[{"name":"University of Gdan\u0301sk , , Wita Stwosza 63 , ,","place":["Gdan\u0301sk, Poland, 80-308"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-1590","authenticated-orcid":true,"given":"Mateusz","family":"Kowalik","sequence":"additional","affiliation":[{"name":"University of Gdan\u0301sk , , Wita Stwosza 63 , ,","place":["Gdan\u0301sk, Poland, 80-308"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Maciejewska","sequence":"additional","affiliation":[{"name":"Gdan\u0301sk University of Technology , , Gabriela Narutowicza 11\/12 , ,","place":["Gdan\u0301sk, Poland, 80-233"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3428-5705","authenticated-orcid":true,"given":"Jan","family":"Alfuth","sequence":"additional","affiliation":[{"name":"Gdan\u0301sk University of Technology , , Gabriela Narutowicza 11\/12 , ,","place":["Gdan\u0301sk, Poland, 80-233"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-3276","authenticated-orcid":true,"given":"Dawid","family":"De\u0328bowski","sequence":"additional","affiliation":[{"name":"University of Gdan\u0301sk , , Wita Stwosza 63 , ,","place":["Gdan\u0301sk, Poland, 80-308"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kazimierczuk","sequence":"additional","affiliation":[{"name":"Gdan\u0301sk University of Technology , , Gabriela Narutowicza 11\/12 , ,","place":["Gdan\u0301sk, Poland, 80-233"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7342-722X","authenticated-orcid":true,"given":"Mariusz","family":"Makowski","sequence":"additional","affiliation":[{"name":"University of Gdan\u0301sk , , Wita Stwosza 63 , ,","place":["Gdan\u0301sk, Poland, 80-308"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"3","key":"2026101908275010800_cit1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics\n2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for\n36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca-Cancer J. Clin."},{"issue":"16","key":"2026101908275010800_cit2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.bmcl.2019.06.041","article-title":"Sulfonamide\nDerivatives as Multi-Target Agents for\nComplex Diseases","volume":"29","author":"Apayd\u0131n","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"29","key":"2026101908275010800_cit3","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202502122","article-title":"Sulfonamides:\nHistorical Perspectives,\nTherapeutic Insights, Applications, Challenges, and Synthetic Strategies","volume":"10","author":"Chhablani","year":"2025","journal-title":"ChemistrySelect"},{"issue":"12","key":"2026101908275010800_cit4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.31838\/srp.2020.12.218","article-title":"The Recent Progress of Sulfonamide in Medicinal Chemistry","volume":"11","author":"Oudah","year":"2020","journal-title":"Syst. Rev. Pharm."},{"key":"2026101908275010800_cit5","doi-asserted-by":"publisher","first-page":"107409","DOI":"10.1016\/j.bioorg.2024.107409","article-title":"Sulfonamides\nas Anticancer Agents: A Brief Review on Sulfonamide Derivatives as\nInhibitors of Various Proteins Overexpressed in Cancer","volume":"147","author":"Elsayad","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"2","key":"2026101908275010800_cit6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/0929867329666220729151500","article-title":"Sulfonamide Moiety\nas \u201cMolecular Chimera\u201d in the Design of New Drugs","volume":"30","author":"Culletta","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"2026101908275010800_cit7","doi-asserted-by":"publisher","first-page":"113409","DOI":"10.1016\/j.jinorgbio.2026.113409","article-title":"A Review on Sulfonamides\nand Their Coordination Compounds: Fighting Diseases and Catalytic\nApplications","volume":"284","author":"Kowalik","year":"2026","journal-title":"J. Inorg. Biochem."},{"issue":"7","key":"2026101908275010800_cit8","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202403434","article-title":"Sulfonamides\nas a Promising Scaffold in Drug Discovery: An Insightful Review on\nFDA-Approved Molecules, Synthesis Strategy, Medical Indication, and\nTheir Binding Mode","volume":"22","author":"Aslam","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"12","key":"2026101908275010800_cit9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1080\/17568919.2024.2351291","article-title":"Recent Development\nof Azole\u2013Sulfonamide Hybrids\nwith the Anticancer Potential","volume":"16","author":"Zhao","year":"2024","journal-title":"Future Med. Chem."},{"issue":"15","key":"2026101908275010800_cit10","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1002\/anie.201610456","article-title":"Sulfonimidamides\nin Medicinal and Agricultural Chemistry","volume":"56","author":"Chinthakindi","year":"2017","journal-title":"Angew.\nChem., Int. Ed."},{"issue":"11","key":"2026101908275010800_cit11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.53879\/id.49.11.p0005","article-title":"The Scope of Metal Complexes in Drug Design - a Review","volume":"49","author":"Pattan","year":"2012","journal-title":"Indian Drugs"},{"issue":"8","key":"2026101908275010800_cit12","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1039\/C5DT03919C","article-title":"Metal-Based Drugs That Break the Rules","volume":"45","author":"Allardyce","year":"2016","journal-title":"Dalton Trans."},{"issue":"12","key":"2026101908275010800_cit13","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3390\/pharmaceutics15122750","article-title":"Research Progress\nof Metal Anticancer Drugs","volume":"15","author":"Bai","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026101908275010800_cit14","doi-asserted-by":"publisher","first-page":"100569","DOI":"10.1016\/j.mtadv.2025.100569","article-title":"Recent Advances in Metallodrug: Coordination-Induced\nSynergy between\nClinically Approved Drugs and Metal Ions","volume":"25","author":"Kim","year":"2025","journal-title":"Mater.\nToday Adv."},{"issue":"19","key":"2026101908275010800_cit15","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The Side\nEffects of Platinum-Based\nChemotherapy Drugs: A Review for Chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton\nTrans."},{"issue":"3","key":"2026101908275010800_cit16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/medicina59030544","article-title":"Ovarian Cancer Insights\ninto Platinum Resistance and Overcoming It","volume":"59","author":"Havasi","year":"2023","journal-title":"Medicina"},{"issue":"1","key":"2026101908275010800_cit17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13048-024-01523-z","article-title":"ADC: A Deadly Killer\nof Platinum Resistant Ovarian Cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Ovarian\nRes."},{"issue":"7","key":"2026101908275010800_cit18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.trechm.2021.03.006","article-title":"Metal Complexes\nfor Therapeutic Applications","volume":"3","author":"Karges","year":"2021","journal-title":"Trends Chem."},{"key":"2026101908275010800_cit19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal Complexes\nin Cancer Therapy\n\u2013 an Update from Drug Design Perspective","volume":"11","author":"Ndagi","year":"2017","journal-title":"Drug Des., Dev. Ther."},{"issue":"2","key":"2026101908275010800_cit20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1021\/acscentsci.3c01340","article-title":"Metals in\nCancer Research: Beyond Platinum Metallodrugs","volume":"10","author":"Casini","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"2026101908275010800_cit21","doi-asserted-by":"publisher","first-page":"123144","DOI":"10.1016\/j.jorganchem.2024.123144","article-title":"A Multifaceted\nApproach towards Organometallic Anticancer Agent Development","volume":"1012","author":"Hartinger","year":"2024","journal-title":"J. Organomet. Chem."},{"issue":"12","key":"2026101908275010800_cit22","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1039\/D4QI00625A","article-title":"Luminescent Iridium(III)\u2013Peptide\nBioconjugates for Bioanalytical and Biomedical Applications","volume":"11","author":"Jing","year":"2024","journal-title":"Inorg. Chem. Front."},{"key":"2026101908275010800_cit23","doi-asserted-by":"publisher","first-page":"113308","DOI":"10.1016\/j.ejmech.2021.113308","article-title":"Recent Advances in\nBiological Activities of Rhodium Complexes: Their Applications in\nDrug Discovery Research","volume":"216","author":"Sohrabi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"2026101908275010800_cit24","doi-asserted-by":"publisher","first-page":"1025544","DOI":"10.3389\/fphar.2022.1025544","article-title":"Current Status of Iridium-Based\nComplexes against Lung Cancer","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"2026101908275010800_cit25","doi-asserted-by":"publisher","first-page":"101941","DOI":"10.1016\/j.mtbio.2025.101941","article-title":"Rhodium-Based Metallodrugs\nfor Biological Applications: Current Status and Future Perspectives","volume":"33","author":"Xiang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"2026101908275010800_cit26","doi-asserted-by":"publisher","first-page":"123814","DOI":"10.1016\/j.jorganchem.2025.123814","article-title":"Iridium Complexes\nin Cancer Treatment: A Promising Complement to Cis-Platin \u2013\nA Mini Review","volume":"1040","author":"Mandal","year":"2025","journal-title":"J. Organomet. Chem."},{"key":"2026101908275010800_cit27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/0470864052.ch20","article-title":"45Rh Rhodium in Medicine","volume-title":"Metallotherapeutic\nDrugs and Metal-based Diagnostic Agents","author":"Pruchnik","year":"2005"},{"issue":"9","key":"2026101908275010800_cit28","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ph18091414","article-title":"A Review on Sulfonamide Complexes with Metals: Their\nPharmacological Potential as Anticancer Drugs","volume":"18","author":"Rozbicki","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"4","key":"2026101908275010800_cit29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00775-019-01665-2","article-title":"Similarities\nand Differences\nin D6 Low-Spin Ruthenium, Rhodium and Iridium Half-Sandwich Complexes:\nSynthesis, Structure, Cytotoxicity and Interaction with Biological\nTargets","volume":"24","author":"Gilewska","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"issue":"6","key":"2026101908275010800_cit30","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1039\/C3DT52743C","article-title":"Phenanthroline Ligands Are Biologically More Active\nthan Their Corresponding Ruthenium(Ii) Arene Complexes","volume":"43","author":"Valladolid","year":"2014","journal-title":"Dalton Trans."},{"issue":"9","key":"2026101908275010800_cit31","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/cmdc.200800097","article-title":"Phenanthroline Derivatives with Improved\nSelectivity as DNA-Targeting Anticancer or Antimicrobial Drugs","volume":"3","author":"Roy","year":"2008","journal-title":"ChemMedChem"},{"issue":"5","key":"2026101908275010800_cit32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.7546\/CRABS.2019.05.08","article-title":"Anticancer Activity of Molecular\nComplexes of 1,10-Phenanthroline and 5-Amino-1,10-Phenanthroline against\nProstate and Breast Cancer Cell Lines","volume":"72","author":"Zasheva","year":"2019","journal-title":"C. R.\nAcad. Bulg. Sci."},{"issue":"1","key":"2026101908275010800_cit33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.7546\/CRABS.2019.01.10","article-title":"Antimicrobial\nActivity of New Molecular\nComplexes of 1,10-Phenanthroline and 5-Amino-1,10-Phenanthroline on\nEscherichia Coli and Saccharomyces Cerevisiae Strains","volume":"72","author":"Alexandar","year":"2019","journal-title":"C. R. Acad. Bulg. Sci."},{"issue":"13","key":"2026101908275010800_cit34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/zaac.201900317","article-title":"Metal and Substituent Influence on the Cytostatic Activity\nof Cationic Bis-Cyclometallated Iridium and Rhodium Complexes with\nSubstituted 1,10-Phenanthrolines as Ancillary Ligands","volume":"646","author":"Graf","year":"2020","journal-title":"Z. Anorg. Allg. Chem."},{"key":"2026101908275010800_cit35","doi-asserted-by":"publisher","first-page":"123003","DOI":"10.1016\/j.ica.2025.123003","article-title":"Cyclopentadienyl\nIr(III) Complexes as Photosensitizers for Antibacterial Photodynamic\nTherapy: Experimental and Computational Insights","volume":"591","author":"Mandal","year":"2026","journal-title":"Inorg. Chim. Acta"},{"issue":"9","key":"2026101908275010800_cit36","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/cryst11091076","article-title":"Synthesis, Crystal\nStructure, Inhibitory Activity and Molecular Docking of Coumarins\/Sulfonamides\nContaining Triazolyl Pyridine Moiety as Potent Selective Carbonic\nAnhydrase IX and XII Inhibitors","volume":"11","author":"Aimene","year":"2021","journal-title":"Crystals"},{"issue":"6","key":"2026101908275010800_cit37","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/biomedicines10061437","article-title":"Sulfonamide-Derived\nDithiocarbamate Gold(I) Complexes Induce the Apoptosis of Colon Cancer\nCells by the Activation of Caspase 3 and Redox Imbalance","volume":"10","author":"Quero","year":"2022","journal-title":"Biomedicines"},{"issue":"28","key":"2026101908275010800_cit38","doi-asserted-by":"publisher","first-page":"10244","DOI":"10.1039\/c3dt50416f","article-title":"Mixed-Ligand Copper(Ii)\u2013Sulfonamide Complexes:\nEffect of the Sulfonamide Derivative on DNA Binding, DNA Cleavage,\nGenotoxicity and Anticancer Activity","volume":"42","author":"Gonza\u0301lez-A\u0301lvarez","year":"2013","journal-title":"Dalton\nTrans."},{"issue":"20","key":"2026101908275010800_cit39","doi-asserted-by":"publisher","first-page":"9246","DOI":"10.1021\/acs.jmedchem.8b00958","article-title":"In Vivo Selectivity and Localization of Reactive Oxygen Species\n(ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum\nResistance","volume":"61","author":"Coverdale","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026101908275010800_cit40","doi-asserted-by":"publisher","first-page":"41858","DOI":"10.1038\/s41598-025-25904-6","article-title":"A Novel Sulfonamide\nDerivative Suppresses Gastrointestinal Cancer Progression by Targeting\nAxin2 and \u03b2-Catenin","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"issue":"23","key":"2026101908275010800_cit41","doi-asserted-by":"publisher","first-page":"21364","DOI":"10.1021\/acs.jmedchem.4c02284","article-title":"Biological\nEvaluation of a Rhodium(III) Bipyridylsulfonamide Complex: Effects\non Mitochondrial Dynamics and Cytoskeletal Remodeling in Breast Cancer\nCells","volume":"67","author":"Audzeyenka","year":"2024","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026101908275010800_cit42","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1021\/acs.inorgchem.3c03801","article-title":"Anticancer Study on IrIII and RhIII Half-Sandwich Complexes with the Bipyridylsulfonamide\nLigand","volume":"63","author":"Kowalik","year":"2024","journal-title":"Inorg. Chem."},{"key":"2026101908275010800_cit43","article-title":"X-Area 1.75,\nSoftware Package for\nCollecting Single-Crystal Data on STOE Area-Detector Diffractometers,\nfor Image Processing","volume-title":"Scaling Reflection\nIntensities and for Outlier Rejection","author":"STOE & Cie GmbH.","year":"2015"},{"issue":"1","key":"2026101908275010800_cit44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT \u2013 Integrated Space-Group and Crystal-Structure\nDetermination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A: Found. Adv."},{"issue":"1","key":"2026101908275010800_cit45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal\nStructure Refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct. Chem."},{"issue":"2","key":"2026101908275010800_cit46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: A Complete Structure Solution,\nRefinement and Analysis Program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"2026101908275010800_cit47","volume-title":"Diamond-Crystal and Molecular\nStructure Visualisation","author":"Brandenburg","year":"1997"},{"key":"2026101908275010800_cit48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.molliq.2018.11.147","article-title":"Drug-like Properties and Complete Physicochemical Profile\nof Pyrazine-2-amidoxime: A Combined Multi-Experimental and Computational\nStudies","volume":"276","author":"Chylewska","year":"2019","journal-title":"J. Mol. Liq."},{"key":"2026101908275010800_cit49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphotobiol.2013.03.013","article-title":"Drug\u2013DNA Interactions\nand Their Study by UV\u2013Visible,\nFluorescence Spectroscopies and Cyclic Voltametry","volume":"124","author":"Sirajuddin","year":"2013","journal-title":"J. Photochem. Photobiol. B: Biol."},{"issue":"3","key":"2026101908275010800_cit50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1432-1033.1974.tb03295.x","article-title":"A Spectroscopic\nStudy of the Haemin\u2013Human-Serum-Albumin System","volume":"41","author":"Beaven","year":"1974","journal-title":"Eur. J. Biochem."},{"issue":"35","key":"2026101908275010800_cit51","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1039\/D1CE00869B","article-title":"Experimental and Theoretical Investigation\nof Conformational\nStates and Noncovalent Interactions in Crystalline Sulfonamides with\na Methoxyphenyl Moiety","volume":"23","author":"Kowalik","year":"2021","journal-title":"CrystEngComm"},{"key":"2026101908275010800_cit52","doi-asserted-by":"publisher","first-page":"115865","DOI":"10.1016\/j.poly.2022.115865","article-title":"Sulfonamides with Hydroxyphenyl Moiety:\nSynthesis,\nStructure, Physicochemical Properties, and Ability to Form Complexes\nwith Rh(III) Ion","volume":"221","author":"Gawron\u0301ska","year":"2022","journal-title":"Polyhedron"},{"issue":"9","key":"2026101908275010800_cit53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1039\/B617136B","article-title":"Structural Variation in Copper(I)\nComplexes with Pyridylmethylamide Ligands: Structural Analysis with\na New Four-Coordinate Geometry Index, \u03a44","volume":"36","author":"Yang","year":"2007","journal-title":"Dalton Trans."},{"issue":"1","key":"2026101908275010800_cit54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ci7002494","article-title":"Small Molecule Conformational\nPreferences Derived from Crystal Structure Data. A Medicinal Chemistry\nFocused Analysis","volume":"48","author":"Brameld","year":"2008","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"2026101908275010800_cit55","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1021\/cg400666v","article-title":"Sulfonamide\nMolecular Crystals: Structure, Sublimation Thermodynamic Characteristics,\nMolecular Packing, Hydrogen Bonds Networks","volume":"13","author":"Perlovich","year":"2013","journal-title":"Cryst. Growth Des."},{"issue":"5","key":"2026101908275010800_cit56","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1021\/acs.cgd.9b00159","article-title":"Characteristic Hydrogen Bonding Observed\nin the Crystals of Aromatic Sulfonamides: 1D Chain Assembly of Molecules\nand Chiral Discrimination on Crystallization","volume":"19","author":"Kikkawa","year":"2019","journal-title":"Cryst. Growth Des."},{"issue":"12","key":"2026101908275010800_cit57","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/jps.1157","article-title":"Hydrogen Bonding in Sulfonamides","volume":"90","author":"Adsmond","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"2026101908275010800_cit58","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1021\/jm00106a056","article-title":"Hydrophobicity Parameters\nfor Platinum Complexes","volume":"34","author":"Souchard","year":"1991","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026101908275010800_cit59","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1021\/jm3002857","article-title":"In Vitro Anticancer\nActivity of Cis-Diammineplatinum(II)\nComplexes with \u03b2-Diketonate Leaving Group Ligands","volume":"55","author":"Wilson","year":"2012","journal-title":"J. Med. Chem."},{"issue":"7","key":"2026101908275010800_cit60","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.jinorgbio.2007.12.029","article-title":"Calculation\nof Lipophilicity for Pt(II) Complexes: Experimental Comparison of\nSeveral Methods","volume":"102","author":"Tetko","year":"2008","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"2026101908275010800_cit61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/10826060008544944","article-title":"Purification and Characterization\nof Carbonic Anhydrase from Bovine Erythrocyte Plasma Membrane","volume":"30","author":"Demir","year":"2000","journal-title":"Prep. Biochem. Biotechnol."},{"issue":"1","key":"2026101908275010800_cit62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/14756360410001689612","article-title":"Purification\nand Characterization\nof Carbonic Anhydrase from Bovine Stomach and Effects of Some Known\nInhibitors on Enzyme Activity","volume":"20","author":"DemI\u0307r","year":"2005","journal-title":"J. Enzyme Inhib.\nMed. Chem."},{"issue":"8","key":"2026101908275010800_cit63","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple Binding\nModes of Inhibitors to Carbonic Anhydrases: How to Design Specific\nDrugs Targeting 15 Different Isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem.\nRev."},{"key":"2026101908275010800_cit64","doi-asserted-by":"publisher","first-page":"116200","DOI":"10.1016\/j.molliq.2021.116200","article-title":"Studying the\nInteraction of Drug\/Ligand with Serum Albumin","volume":"336","author":"Siddiqui","year":"2021","journal-title":"J. Mol. Liq."},{"issue":"1","key":"2026101908275010800_cit65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0167-4838(98)00011-9","article-title":"Interaction\nof Cisplatin with Human Serum Albumin.\nDrug Binding Mode and Protein Secondary Structure","volume":"1384","author":"Neault","year":"1998","journal-title":"Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol."},{"key":"2026101908275010800_cit66","doi-asserted-by":"publisher","first-page":"120737","DOI":"10.1016\/j.molliq.2022.120737","article-title":"Shedding Light on the\nMolecular Interaction between\nthe Hepatitis B Virus Inhibitor, Clevudine, and Human Serum Albumin:\nThermodynamic, Spectroscopic, Microscopic, and in Silico Analyses","volume":"368","author":"Abubakar","year":"2022","journal-title":"J. Mol. Liq."},{"issue":"2","key":"2026101908275010800_cit67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/molecules21020153","article-title":"Binding\nbetween Saikosaponin C and Human Serum Albumin by Fluorescence Spectroscopy\nand Molecular Docking","volume":"21","author":"Chen","year":"2016","journal-title":"Molecules"},{"issue":"9","key":"2026101908275010800_cit68","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1021\/acsptsci.2c00115","article-title":"Using Human Serum Albumin Binding Affinities as a Proactive Strategy\nto Affect the Pharmacodynamics and Pharmacokinetics of Preclinical\nDrug Candidates","volume":"5","author":"Fan","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"2","key":"2026101908275010800_cit69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ygyno.2011.04.034","article-title":"The Impact of S-\nand G2-Checkpoint Response on the Fidelity of G1-Arrest by Cisplatin\nand Its Comparison to a Non-Cross-Resistant Platinum(IV) Analog","volume":"122","author":"He","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"2026101908275010800_cit70","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1158\/1078-0432.CCR-14-2300","article-title":"Effective\nTargeting of the P53\/MDM2 Axis in Preclinical Models of Infant MLL-Rearranged\nAcute Lymphoblastic Leukemia","volume":"21","author":"Richmond","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"2026101908275010800_cit71","first-page":"6311","article-title":"The Intrinsic\nMitochondrial Membrane Potential (\u0394\u03c8m) Is Associated with\nSteady-State Mitochondrial Activity and the Extent to Which Colonic\nEpithelial Cells Undergo Butyrate-Mediated Growth Arrest and Apoptosis1","volume":"63","author":"Heerdt","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"2026101908275010800_cit72","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the Mitochondrial Membrane\nPotential Using the Cationic JC-1 Dyeas a Sensitive Fluorescent Probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio-Protoc."},{"issue":"23","key":"2026101908275010800_cit73","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1091\/mbc.e09-07-0649","article-title":"Caspase-Independent Mitochondrial Cell Death Results\nfrom Loss of Respiration, Not Cytotoxic Protein Release","volume":"20","author":"Lartigue","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"2026101908275010800_cit74","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbrc.2021.04.104","article-title":"VDAC1 as a Target in Cisplatin Anti-Tumor Activity\nthrough Promoting Mitochondria Fusion","volume":"560","author":"Lou","year":"2021","journal-title":"Biochem.\nBiophys. Res. Commun."},{"key":"2026101908275010800_cit75","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin\nin Cancer Therapy: Molecular Mechanisms of\nAction","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"2026101908275010800_cit76","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1074\/jbc.275.13.9390","article-title":"Initiation of DNA Fragmentation\nduring Apoptosis\nInduces Phosphorylation of H2AX Histone at Serine 139","volume":"275","author":"Rogakou","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"5","key":"2026101908275010800_cit77","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2005.10.003","article-title":"\u03b3-H2AX Dephosphorylation by Protein Phosphatase\n2A Facilitates DNA Double-Strand Break Repair","volume":"20","author":"Chowdhury","year":"2005","journal-title":"Mol. Cell"},{"issue":"11","key":"2026101908275010800_cit78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin Induces a Mitochondrial-ROS\nResponse That Contributes to Cytotoxicity Depending on Mitochondrial\nRedox Status and Bioenergetic Functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS\nOne"},{"key":"2026101908275010800_cit79","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and\nthe DNA Damage Response in Cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol."},{"issue":"5","key":"2026101908275010800_cit80","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41418-023-01141-0","article-title":"A Noncanonical\nResponse to Replication Stress Protects Genome Stability through ROS\nProduction, in an Adaptive Manner","volume":"30","author":"Ragu","year":"2023","journal-title":"Cell Death\nDiffer."}],"container-title":["Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.inorgchem.6c04078","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/inocaj\/article-pdf\/65\/41\/24456\/68732317\/acs.inorgchem.6c04078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/inocaj\/article-pdf\/65\/41\/24456\/68732317\/acs.inorgchem.6c04078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:43:47Z","timestamp":1792413827000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/inocaj\/article\/65\/41\/24456\/5443702\/Metal-dependent-Structure-Solution-Properties-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":80,"journal-issue":{"issue":"41","published-online":{"date-parts":[[2026,10,2]]},"published-print":{"date-parts":[[2026,10,19]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.inorgchem.6c04078","relation":{},"ISSN":["0020-1669","1520-510X"],"issn-type":[{"value":"0020-1669","type":"print"},{"value":"1520-510X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}